S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Fund/Deep Track Capital/Q1 2023

Deep Track Capital

Periodo: Q1 2023 Β· Depositato: 2023-05-15
Vedi su SEC EDGAR β†—
AUM
$2.43B
Valore totale del portafoglio
Posizioni
58
Titoli dichiarati
Prima Posizione
JAZZ
7.2% $175.6M
Var. Trimestrali
+8 / -8
nuovi Β· usciti
⚠️Informativa sui Depositi 13F

I dati AUM mostrati sono calcolati sommando il valore di mercato dichiarato di tutte le posizioni nei depositi SEC 13F-HR β€” non rappresentano il patrimonio effettivo gestito dal fondo.

  • Escluse liquiditΓ , obbligazioni, private equity, posizioni corte e azioni estere non soggette all'obbligo di dichiarazione.
  • Per le opzioni PUT e CALL, il Valore dichiarato Γ¨ il valore nozionale delle azioni sottostanti β€” non il premio pagato. CiΓ² sovrastima significativamente il capitale effettivamente a rischio.
  • Il patrimonio reale del fondo Γ¨ tipicamente superiore e include strategie, strumenti e posizioni che non compaiono mai in un 13F.
  • I depositi 13F riguardano i gestori istituzionali con β‰₯$100M in titoli 13F. Le posizioni riflettono le partecipazioni a fine trimestre, divulgate entro 45 giorni dalla fine del periodo.

Dati provenienti da SEC EDGAR. Questo tracker Γ¨ a scopo puramente informativo e non costituisce consulenza finanziaria.

Partecipazioni in Portafoglio

Prime 30 posizioni

⚠️ Performance % calcolata dalla data di deposito ( 2023-05-15) si riferisce al titolo sottostante β€” non al P&L del derivato.
TickerEmittenteNozionalePortafoglio %Al DepositoOra (Fine Giornata)Dal DepositoAllocazione
JAZZJAZZ PHARMACEUTICALS PLC$175.6M7.21%$146.33$243.47+66.4%
7.2%
ISEEIVERIC BIO INC$158.2M6.50%β€”β€”
6.5%
TVTXTRAVERE THERAPEUTICS INC$138.3M5.68%$22.49$56.92+153.1%
5.7%
IMVTIMMUNOVANT INC$115.3M4.73%$15.51$38.79+150.1%
4.7%
INSMINSMED INC$110.8M4.55%$17.05$111.60+554.5%
4.5%
IONSIONIS PHARMACEUTICALS INC$101.3M4.16%$35.74$81.80+128.9%
4.2%
ITCIINTRA-CELLULAR THERAPIES INC$92.1M3.78%β€”β€”
3.8%
PLRXPLIANT THERAPEUTICS INC$91.0M3.74%$26.60$1.17-95.6%
3.7%
ALKSALKERMES PLC$84.6M3.47%$28.19$54.58+93.6%
3.5%
SWTXSPRINGWORKS THERAPEUTICS INC$79.8M3.28%β€”β€”
3.3%
KDNYCHINOOK THERAPEUTICS INC$69.5M2.85%β€”β€”
2.9%
RETAREATA PHARMACEUTICALS INC$66.3M2.72%β€”β€”
2.7%
VRNAVERONA PHARMA PLC$64.0M2.63%β€”β€”
2.6%
GPCRSTRUCTURE THERAPEUTICS INC$63.0M2.59%$23.79$53.45+124.7%
2.6%
DVAXDYNAVAX TECHNOLOGIES CORP$62.3M2.56%β€”β€”
2.6%
BCYCBICYCLE THERAPEUTICS PLC$60.0M2.46%$21.27$4.35-79.5%
2.5%
GERNGERON CORP$58.3M2.39%$2.17$1.36-37.3%
2.4%
BIIBBIOGEN INC$55.6M2.28%$278.03$216.12-22.3%
2.3%
DICEDICE THERAPEUTICS INC$45.8M1.88%β€”β€”
1.9%
AGENAGENUS INC$45.6M1.87%$29.83$3.49-88.3%
1.9%
SGENPUTSEAGEN INC$44.1M1.81%β€”β€”
1.8%
PACBPACIFIC BIOSCIENCES CALIF IN$40.6M1.67%$11.58$1.68-85.5%
1.7%
FDMT4D MOLECULAR THERAPEUTICS IN$39.2M1.61%$17.19$13.00-24.4%
1.6%
BEAMBEAM THERAPEUTICS INC$38.3M1.57%$30.62$34.79+13.6%
1.6%
EXELEXELIXIS INC$37.5M1.54%$19.41$55.85+187.7%
1.5%
ARGXPUTARGENX SE$37.3M1.53%$372.58$939.68+152.2%
1.5%
VRDNVIRIDIAN THERAPEUTICS INC$31.3M1.29%$25.44$19.40-23.7%
1.3%
AUTLAUTOLUS THERAPEUTICS PLC$27.6M1.13%$1.84$1.58-14.1%
1.1%
ETNB89BIO INC$27.4M1.13%β€”β€”
1.1%
DYNDYNE THERAPEUTICS INC$26.9M1.10%$11.52$23.07+100.3%
1.1%

AttivitΓ  Trimestre su Trimestre

Q1 2023 vs. Q4 2022

Nuove Posizioni (8)

TickerEmittenteNozionaleDal Deposito
ITCIINTRA-CELLULAR THERAPIES INC$92.1M
ALKSALKERMES PLC$84.6M+93.6%
GPCRSTRUCTURE THERAPEUTICS INC$63.0M+124.7%
SGENPUTSEAGEN INC$44.1M
PACBPACIFIC BIOSCIENCES CALIF IN$40.6M-85.5%
EXELEXELIXIS INC$37.5M+187.7%
ARGXPUTARGENX SE$37.3M+152.2%
DCPHDECIPHERA PHARMACEUTICALS IN$21.1M

Posizioni Chiuse (8)

TickerEmittenteNozionale
ASNDASCENDIS PHARMA A/S$85.5M
SRPTSAREPTA THERAPEUTICS INC$68.5M
HZNPHORIZON THERAPEUTICS PUB L$56.9M
HZNPHORIZON THERAPEUTICS PUB L$56.9M
ALBOALBIREO PHARMA INC$36.8M
ASNDASCENDIS PHARMA A/S$30.4M
ESPRESPERION THERAPEUTICS INC NE$24.9M
BMRNBIOMARIN PHARMACEUTICAL INC$19.6M

Aumentate (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
RETAREATA PHARMACEUTICALS INC$65.8M+5685.7%
GERNGERON CORP$40.4M+262.4%-37.3%
DVAXDYNAVAX TECHNOLOGIES CORP$37.5M+172.8%
IONSIONIS PHARMACEUTICALS INC$55.8M+135.0%+128.9%
PLRXPLIANT THERAPEUTICS INC$57.5M+97.5%-95.6%
INSMINSMED INC$25.6M+52.4%+554.5%
IPSCCENTURY THERAPEUTICS INC$-0.0M+47.0%
JAZZJAZZ PHARMACEUTICALS PLC$36.4M+37.4%+66.4%

Ridotte (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
ETNBPUT89BIO INC$-48.9M-99.9%
RAPTRAPT THERAPEUTICS INC$-15.4M-56.2%
ETNBPUT89BIO INC$-21.6M-53.2%
HRTXHERON THERAPEUTICS INC$-11.4M-50.2%
BIIBBIOGEN INC$-27.5M-33.3%-22.3%
VRDNVIRIDIAN THERAPEUTICS INC$-20.4M-30.5%-23.7%
ALLKALLAKOS INC$-25.3M-26.8%
IMVTIMMUNOVANT INC$-57.1M-23.5%+150.1%
← Torna agli Hedge Fund